PSUSA/00001997/202403
Submitted by Anonymous (not verified) on 4 November 2024 - 9:27
PSUSA/00001997/202403
Human medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 10, Status: Authorised
Submitted by Anonymous (not verified) on 30 October 2024 - 15:10
Human medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 10, Status: Authorised
Pegasys (peginterferon alfa-2a) supply shortage
Submitted by Anonymous (not verified) on 30 October 2024 - 13:36
Pegasys (peginterferon alfa-2a) supply shortage
Product Management Service (PMS) – Frequently Asked Questions (FAQs)
Submitted by Anonymous (not verified) on 30 October 2024 - 13:21
Product Management Service (PMS) – Frequently Asked Questions (FAQs)
EMA closed 1 November
Submitted by Anonymous (not verified) on 30 October 2024 - 13:00
EMA closed 1 November
Advancing regulatory science research, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2024, 13:30 (CET) to 18 November 2024, 17:30 (CET)
Submitted by Anonymous (not verified) on 30 October 2024 - 11:49
Advancing regulatory science research, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2024, 13:30 (CET) to 18 November 2024, 17:30 (CET)
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 30 October 2024 - 11:00
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 30 October 2024 - 11:00
List of medicinal products under additional monitoring
Human medicines European public assessment report (EPAR): Gliolan, 5-aminolevulinic acid hydrochloride, Date of authorisation: 07/09/2007, Revision: 10, Status: Authorised
Submitted by Anonymous (not verified) on 30 October 2024 - 9:32
Human medicines European public assessment report (EPAR): Gliolan, 5-aminolevulinic acid hydrochloride, Date of authorisation: 07/09/2007, Revision: 10, Status: Authorised
mHealth data for real world evidence in regulatory decision-making: expert report for HMA-EMA Big Data Steering Group
Submitted by Anonymous (not verified) on 29 October 2024 - 16:16
mHealth data for real world evidence in regulatory decision-making: expert report for HMA-EMA Big Data Steering Group